Collegium Pharmaceutical, Inc. COLL Symproic — Cost, Amortization
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldAmortization.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s symproic — cost, amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s symproic — cost, amortization?
- Collegium Pharmaceutical, Inc. (COLL) reported symproic — cost, amortization of $1.82M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s symproic — cost, amortization changed year-over-year?
- Collegium Pharmaceutical, Inc.'s symproic — cost, amortization decreased by 0.0% year-over-year, from $1.82M to $1.82M.
- What does symproic — cost, amortization mean?
- The periodic expense recognized for the systematic allocation of the cost of intangible assets related to Symproic over their estimated useful lives. This non-cash charge reflects the ongoing consumption of the asset's value in the production of revenue.